# Fairfax Financial Holdings Ltd/ Can: financial statements, quarterly

FRFHF · OTC · CIK 915191 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frfhf.md) · [Financials](/companies/frfhf/financials.md) · [Filings](/companies/frfhf/filings.md) · [Insiders](/companies/frfhf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frfhf/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [4.6](/filings/0001047469-18-001464.md) | [8.8](/filings/0001047469-19-001031.md) | [5.1](/filings/0001047469-20-001296.md) | [3.9](/filings/0001104659-22-030659.md) | [4.5](/filings/0001104659-23-031240.md) | [11.7](/filings/0001104659-24-032469.md) | [6.1](/filings/0001104659-25-021813.md) | [5.1](/filings/0001104659-26-024781.md) | [6.1](/filings/0001104659-26-024781.md) | [6.2](/filings/0001104659-26-024781.md) |
| Total assets | $bn | not reported | [43.4](/filings/0001047469-18-001464.md) | [64.1](/filings/0001047469-19-001031.md) | [64.4](/filings/0001047469-20-001296.md) | [70.5](/filings/0001047469-21-000519.md) | [74.1](/filings/0001104659-22-030659.md) | [86.6](/filings/0001104659-23-031240.md) | [78.8](/filings/0001104659-24-032469.md) | [92.0](/filings/0001104659-25-021813.md) | [96.8](/filings/0001104659-26-024781.md) | [108](/filings/0001104659-26-024781.md) |
| Total liabilities | $bn | not reported | [31.6](/filings/0001047469-18-001464.md) | [45.7](/filings/0001047469-19-001031.md) | [47.0](/filings/0001047469-20-001296.md) | [52.6](/filings/0001047469-21-000519.md) | [56.5](/filings/0001104659-22-030659.md) | [65.3](/filings/0001104659-23-031240.md) | [55.8](/filings/0001104659-24-032469.md) | [64.3](/filings/0001104659-25-021813.md) | [68.4](/filings/0001104659-26-024781.md) | [76.9](/filings/0001104659-26-024781.md) |
| Shareholders' equity | $bn | [12.0](/filings/0001047469-18-001464.md) | [9.8](/filings/0001047469-18-001464.md) | [13.8](/filings/0001047469-19-001031.md) | [13.1](/filings/0001047469-20-001296.md) | [14.4](/filings/0001047469-21-000519.md) | [13.9](/filings/0001104659-22-030659.md) | [16.4](/filings/0001104659-23-031240.md) | [19.1](/filings/0001104659-24-032469.md) | [23.0](/filings/0001104659-25-021813.md) | [24.1](/filings/0001104659-26-024781.md) | [26.5](/filings/0001104659-26-024781.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 26,176,506 at 2020-12-31, from the cover of the [40-F filed 2021-03-05](/filings/0001047469-21-000519.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.